Category - Pharma Industry News
UK supercharges booster programme over Omicron
Roche’s lung cancer combination treatment improves long-term survival
Allogeneic approaches to CAR-T
European Commission approves Pfizer’s atopic dermatitis treatment
Five-drug combination for ultra-high-risk bone marrow cancer identified
Four trends to watch in pharma facility design for 2022
FDA approves first pre-exposure prophylactic against COVID-19
‘Excitement’ around new data for Enhertu